Mini lung machine tested on tiniest patients

NCT ID NCT06750536

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a small device called the MiniLung petite kit, which helps oxygenate blood and remove carbon dioxide in newborns and children weighing 2 to 8 kilograms who have severe breathing or heart failure. The device works with a console to temporarily take over the work of the lungs and heart. Researchers want to see if it safely improves oxygen levels and stabilizes vital signs within 24 hours. The study will enroll 20 participants and observe their progress.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

MiniLung petite kit (a miniaturized ECMO device used with the Xenios console)

What this could lead to

If successful, this could provide a safe and effective way to support breathing and heart function in very small infants with life-threatening respiratory or cardiac failure.

What could go wrong

This is a small, early observational study with only 20 participants, so results may not apply to all patients. ECMO itself carries risks like bleeding, infection, and blood clots.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute lung injury acute respiratory failure aspiration pneumonia heart failure neonatal aspiration syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Universitätsklinikum Mannheim

    RECRUITING

    Mannheim, 68167, Germany

    Contact Email: •••••@•••••

  • Universitätsklinkum Bonn

    RECRUITING

    Bonn, North Rhine-Westphalia, 53127, Germany

    Contact Email: •••••@•••••